Product References
Combination of tumor necrosis factor-α and epidermal growth factor induces the adrenergic-to-mesenchymal transdifferentiation in SH-SY5Y neuroblastoma cells.
Cancer science
Huang Y,Tsubota S,Nishio N,Takahashi Y,Kadomatsu K
Mon Feb 01 00:00:00 EST 2021
Combination of tumor necrosis factor-α and epidermal growth factor induces the adrenergic-to-mesenchymal transdifferentiation in SH-SY5Y neuroblastoma cells.
Cancer science
Huang Y,Tsubota S,Nishio N,Takahashi Y,Kadomatsu K
Mon Feb 01 00:00:00 EST 2021
Pharmacological treatment with galectin-1 protects against renal ischaemia-reperfusion injury.
Scientific reports
Carlos CP,Silva AA,Gil CD,Oliani SM
Fri Jun 22 00:00:00 EDT 2018
Pharmacological treatment with galectin-1 protects against renal ischaemia-reperfusion injury.
Scientific reports
Carlos CP,Silva AA,Gil CD,Oliani SM
Fri Jun 22 00:00:00 EDT 2018
Loss of GCNT2/I-branched glycans enhances melanoma growth and survival.
Nature communications
Sweeney JG,Liang J,Antonopoulos A,Giovannone N,Kang S,Mondala TS,Head SR,King SL,Tani Y,Brackett D,Dell A,Murphy GF,Haslam SM,Widlund HR,Dimitroff CJ
Wed Aug 22 00:00:00 EDT 2018
Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans.
Nature communications
Giovannone N,Liang J,Antonopoulos A,Geddes Sweeney J,King SL,Pochebit SM,Bhattacharyya N,Lee GS,Dell A,Widlund HR,Haslam SM,Dimitroff CJ
Fri Aug 17 00:00:00 EDT 2018
Galectin-3 Binding Protein Secreted by Breast Cancer Cells Inhibits Monocyte-Derived Fibrocyte Differentiation.
Journal of immunology (Baltimore, Md. : 1950)
White MJ,Roife D,Gomer RH
Sat Aug 15 00:00:00 EDT 2015
Interfering with Gal-1-mediated angiogenesis contributes to the pathogenesis of preeclampsia.
Proceedings of the National Academy of Sciences of the United States of America
Freitag N,Tirado-González I,Barrientos G,Herse F,Thijssen VL,Weedon-Fekjær SM,Schulz H,Wallukat G,Klapp BF,Nevers T,Sharma S,Staff AC,Dechend R,Blois SM
Tue Jul 09 00:00:00 EDT 2013
Galectin-1 prolongs survival of mouse liver allografts from Flt3L-pretreated donors.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Ye Y,Yan S,Jiang G,Zhou L,Xie H,Xie X,Yu X,Ding Y,Tian J,Dai Y,Zheng S
Fri Mar 01 00:00:00 EST 2013
HLA-G regulates the invasive properties of JEG-3 choriocarcinoma cells by controlling STAT3 activation.
Placenta
Liu X,Gu W,Li X
450-39 was used in Cell Culture to demonstrate that human leucocyte antigen-G is able to regulate JEG-3 cell invasion by influencing STAT3 activation, which may underlie the implantation defects accompanying HLA-G hypo-expression in pre-eclampsia.
Fri Nov 01 00:00:00 EDT 2013
Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma.
Blood
Cedeno-Laurent F,Watanabe R,Teague JE,Kupper TS,Clark RA,Dimitroff CJ
Thu Apr 12 00:00:00 EDT 2012
Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells.
Blood
Garín MI,Chu CC,Golshayan D,Cernuda-Morollón E,Wait R,Lechler RI
Thu Mar 01 00:00:00 EST 2007
Transgenic galectin-1 induces maturation of dendritic cells that elicit contrasting responses in naive and activated T cells.
Journal of immunology (Baltimore, Md. : 1950)
Perone MJ,Larregina AT,Shufesky WJ,Papworth GD,Sullivan ML,Zahorchak AF,Stolz DB,Baum LG,Watkins SC,Thomson AW,Morelli AE
Thu Jun 15 00:00:00 EDT 2006